Previous Article | Next Article 
Molecular and Cellular Biology, August 1999, p. 5642-5651, Vol. 19, No. 8
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Progressive Region-Specific De Novo Methylation of the p16 CpG
Island in Primary Human Mammary Epithelial Cell Strains during
Escape from M0 Growth Arrest
David J.
Wong,1,2
Scott A.
Foster,2
Denise A.
Galloway,2 and
Brian J.
Reid2,3,4,*
Molecular and Cellular
Biology,1 Cancer
Biology,2 and GI
Oncology3 Programs, Fred Hutchinson Cancer
Research Center, Seattle, Washington 98109, and Departments of
Medicine and Genetics, University of Washington, Seattle,
Washington 981954
Received 11 March 1999/Accepted 29 April 1999
CpG island methylation plays an important role in normal cellular
processes, such as genomic imprinting and X-chromosome inactivation, as
well as in abnormal processes, such as neoplasia. However, the dynamics
of de novo CpG island methylation, during which a CpG island is
converted from an unmethylated, active state to a densely methylated,
inactive state, are largely unknown. It is unclear whether the
development of de novo CpG island methylation is a progressive process,
in which a subset of CpG sites are initially methylated with a
subsequent increase in methylation density, or a single event, in which
the initial methylation event encompasses the entire CpG island. The
tumor suppressor gene p16/CDKN2a/INK4a (p16) is inactivated by CpG
island methylation during neoplastic progression in a variety of human
cancers. We investigated the development of methylation in the p16 CpG
island in primary human mammary epithelial cell strains during escape
from mortality stage 0 (M0) growth arrest. The methylation
status of 47 CpG sites in the p16 CpG island on individual DNA
molecules was determined by sequencing PCR clones of bisulfite-treated
genomic DNA. The p16 CpG island was initially methylated at a subset of
sites in three discrete regions in association with p16 transcriptional repression and escape from M0 growth arrest. With continued
passage, methylation gradually increased in density and methylation
expanded to sites in adjacent regions. Thus, de novo methylation in the p16 CpG island is a progressive process that is neither site specific nor completely random but instead is region specific. Our results suggest that early detection of methylation in the CpG island of the
p16 gene will require methylation analysis of the three regions and
that the identification of region-specific methylation patterns in
other genes may be essential for an accurate assessment of
methylation-mediated transcriptional silencing.
*
Corresponding author. Mailing address: Cancer Biology
Program, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N.,
C1-015, P.O. Box 19024, Seattle, WA 98109-1024. Phone: (206) 667-6792. Fax: (206) 667-6132. E-mail: mkunz{at}fhcrc.org.
Molecular and Cellular Biology, August 1999, p. 5642-5651, Vol. 19, No. 8
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Hinshelwood, R. A., Melki, J. R., Huschtscha, L. I., Paul, C., Song, J. Z., Stirzaker, C., Reddel, R. R., Clark, S. J.
(2009). Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning. Hum Mol Genet
18: 3098-3109
[Abstract]
[Full Text]
-
Zhao, X., Lu, L., Pokhriyal, N., Ma, H., Duan, L., Lin, S., Jafari, N., Band, H., Band, V.
(2009). Overexpression of RhoA Induces Preneoplastic Transformation of Primary Mammary Epithelial Cells. Cancer Res.
69: 483-491
[Abstract]
[Full Text]
-
Euhus, D. M., Bu, D., Milchgrub, S., Xie, X.-J., Bian, A., Leitch, A. M., Lewis, C. M.
(2008). DNA Methylation in Benign Breast Epithelium in Relation to Age and Breast Cancer Risk. Cancer Epidemiol. Biomarkers Prev.
17: 1051-1059
[Abstract]
[Full Text]
-
Rosso, A., Balsamo, A., Gambino, R., Dentelli, P., Falcioni, R., Cassader, M., Pegoraro, L., Pagano, G., Brizzi, M. F.
(2006). p53 Mediates the Accelerated Onset of Senescence of Endothelial Progenitor Cells in Diabetes. J. Biol. Chem.
281: 4339-4347
[Abstract]
[Full Text]
-
Belinsky, S. A.
(2005). Silencing of genes by promoter hypermethylation: key event in rodent and human lung cancer. Carcinogenesis
26: 1481-1487
[Abstract]
[Full Text]
-
Terai, M., Uyama, T., Sugiki, T., Li, X.-K., Umezawa, A., Kiyono, T.
(2005). Immortalization of Human Fetal Cells: The Life Span of Umbilical Cord Blood-derived Cells Can Be Prolonged without Manipulating p16INK4a/RB Braking Pathway. Mol. Biol. Cell
16: 1491-1499
[Abstract]
[Full Text]
-
Belinsky, S. A., Klinge, D. M., Liechty, K. C., March, T. H., Kang, T., Gilliland, F. D., Sotnic, N., Adamova, G., Rusinova, G., Telnov, V.
(2004). Plutonium targets the p16 gene for inactivation by promoter hypermethylation in human lung adenocarcinoma. Carcinogenesis
25: 1063-1067
[Abstract]
[Full Text]
-
Fukagawa, N. K., Galbraith, R. A.
(2004). Advancing Age and Other Factors Influencing the Balance between Amino Acid Requirements and Toxicity. J. Nutr.
134: 1569S-1574S
[Abstract]
[Full Text]
-
Maley, C. C., Galipeau, P. C., Li, X., Sanchez, C. A., Paulson, T. G., Reid, B. J.
(2004). Selectively Advantageous Mutations and Hitchhikers in Neoplasms: p16 Lesions Are Selected in Barrett's Esophagus. Cancer Res.
64: 3414-3427
[Abstract]
[Full Text]
-
Yates, P. A., Burman, R., Simpson, J., Ponomoreva, O. N., Thayer, M. J., Turker, M. S.
(2003). Silencing of Mouse Aprt Is a Gradual Process in Differentiated Cells. Mol. Cell. Biol.
23: 4461-4470
[Abstract]
[Full Text]
-
Holst, C. R., Nuovo, G. J., Esteller, M., Chew, K., Baylin, S. B., Herman, J. G., Tlsty, T. D.
(2003). Methylation of p16INK4a Promoters Occurs in Vivo in Histologically Normal Human Mammary Epithelia. Cancer Res.
63: 1596-1601
[Abstract]
[Full Text]
-
Ordway, J. M., Curran, T.
(2002). Methylation Matters: Modeling a Manageable Genome. Cell Growth Differ.
13: 149-162
[Full Text]
-
Belinsky, S. A., Palmisano, W. A., Gilliland, F. D., Crooks, L. A., Divine, K. K., Winters, S. A., Grimes, M. J., Harms, H. J., Tellez, C. S., Smith, T. M., Moots, P. P., Lechner, J. F., Stidley, C. A., Crowell, R. E.
(2002). Aberrant Promoter Methylation in Bronchial Epithelium and Sputum from Current and Former Smokers. Cancer Res.
62: 2370-2377
[Abstract]
[Full Text]
-
Lehmann, U., Langer, F., Feist, H., Glockner, S., Hasemeier, B., Kreipe, H.
(2002). Quantitative Assessment of Promoter Hypermethylation during Breast Cancer Development. Am. J. Pathol.
160: 605-612
[Abstract]
[Full Text]
-
Wong, D. J., Paulson, T. G., Prevo, L. J., Galipeau, P. C., Longton, G., Blount, P. L., Reid, B. J.
(2001). p16INK4a Lesions Are Common, Early Abnormalities that Undergo Clonal Expansion in Barrett's Metaplastic Epithelium. Cancer Res.
61: 8284-8289
[Abstract]
[Full Text]
-
Potter, J. D.
(2001). Morphostats: A Missing Concept in Cancer Biology. Cancer Epidemiol. Biomarkers Prev.
10: 161-170
[Abstract]
[Full Text]
-
Herbert, B.-S., Wright, A. C., Passons, C. M., Wright, W. E., Ali, I. U., Kopelovich, L., Shay, J. W.
(2001). Effects of Chemopreventive and Antitelomerase Agents on the Spontaneous Immortalization of Breast Epithelial Cells. JNCI J Natl Cancer Inst
93: 39-45
[Abstract]
[Full Text]
-
Myohanen, S., Baylin, S. B.
(2001). Sequence-specific DNA Binding Activity of RNA Helicase A to the p16INK4a Promoter. J. Biol. Chem.
276: 1634-1642
[Abstract]
[Full Text]
-
Galm, O., Rountree, M. R., Bachman, K. E., Jair, K.-W., Baylin, S. B., Herman, J. G.
(2002). Enzymatic Regional Methylation Assay: A Novel Method to Quantify Regional CpG Methylation Density. Genome Res
12: 153-157
[Abstract]
[Full Text]